Circulating conversion products of C3 in liver disease. Evidence for in vivo activation of the complement system.
- 1 August 1973
- journal article
- Vol. 14 (4) , 509-14
Abstract
Circulating conversion products of the third component of human complement (C3) were sought for in different forms of liver disease by the method of antigen–antibody crossed electrophoresis. Immunochemical determinations of C3 and C4 by the single radial immunodiffusion method were performed simultaneously.This publication has 17 references indexed in Scilit:
- VARIABLE MECHANISMS FOR LOW SERUM-COMPLEMENT IN LIVER DISEASEThe Lancet, 1971
- RELATIONSHIP OF HEPATITIS-ASSOCIATED ANTIGEN (H.A.A.) TO ACUTE AND CHRONIC LIVER INJURYThe Lancet, 1971
- Studies in vivo and in vitro on an abnormality in the metabolism of C3 in a patient with increased susceptibility to infectionJournal of Clinical Investigation, 1970
- High Voltage Agarose Gel Electrophoresis in the Study of C 3 PolymorphismVox Sanguinis, 1970
- Immunofixation Electrophoresis: A Technique for the Study of Protein Polymorphism1Vox Sanguinis, 1969
- In vivo metabolism of complementJournal of Clinical Investigation, 1968
- A CLASSIFICATION OF CHRONIC HEPATITISThe Lancet, 1968
- Studies of the In Vivo Behavior of Human C′3 in Normal Subjects and Patients*Journal of Clinical Investigation, 1967
- Immunochemical quantitation of antigens by single radial immunodiffusionImmunochemistry, 1965
- Antigen-antibody crossed electrophoresisAnalytical Biochemistry, 1965